3 months to expiry Ghana · FDA Ghana

VAXIPET R INJECTABLE INACTIVATED VACCINE (RABIES INACTIVATION VIRUS SAD UNUKO40-32)

RABIES INACTIVATION VIRUS SAD UNUKO40-32

What it does

Inactivation is a process that reduces or eliminates the activity of a substance, often used in the context of medications or biological agents.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/VVC/251-06010
Registration date
2025-06-26
Expiry date
2026-07-01
Status
3 months to expiry
Active ingredient
RABIES INACTIVATION VIRUS SAD UNUKO40-32
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Bioueta
Country of origin
CZECH REPUBLIC
Manufacturer location
12, Komenského 212, 683 23 Ivanovice na Hané, Czechia

Source: Food and Drugs Authority · fetched 2026-04-18 08:33:00 · updated 2026-06-30 04:00:17

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About inactivation

Inactivation is a process that reduces or eliminates the activity of a substance, often used in the context of medications or biological agents.

How it works

Inactivation involves neutralizing or deactivating a substance so it no longer has an effect.

Who it's for

Inactivation processes are relevant in various medical treatments and research settings.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About rabies

Rabies is a viral infection that affects the brain and spinal cord, usually transmitted through animal bites.

What it treats

  • protection against rabies after exposure
  • post-exposure prophylaxis for rabies

How it works

Rabies vaccines help your body build immunity against the rabies virus.

Who it's for

This treatment is for anyone who has been bitten by an animal that may carry rabies.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About sad

Sad is a medication used to treat certain health conditions.

How it works

The exact way Sad works is not specified, but it helps improve the condition it is prescribed for.

Who it's for

Sad may be prescribed for individuals with specific health issues, but more details are needed for clarity.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About virus

Viruses are microscopic organisms that can cause infections in humans, animals, and plants.

What it treats

  • viral infections
  • common cold
  • influenza (flu)
  • HIV/AIDS
  • hepatitis

How it works

Viruses invade living cells and use them to reproduce, which can lead to illness.

Who it's for

Viruses can affect anyone, but some groups, like those with weakened immune systems, are more at risk.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: inactivation

Inactivation refers to the process of rendering a drug inactive or less active within the body. This can occur through various biochemical pathways, including metabolic processes that transform the drug into less active compounds or through physical actions that prevent the drug from exerting its therapeutic effects. Inactivation is an important concept in pharmacology, as it influences drug efficacy and safety.

Dosage

Children: Refer to specific drug guidelines for dosing, as inactivation does not have a standard dosage.

Adults: Refer to specific drug guidelines for dosing, as inactivation does not have a standard dosage.

Mechanism of action

Inactivation of drugs generally involves enzymatic conversion, where metabolic enzymes modify the drug's structure. This may include processes such as oxidation, reduction, hydrolysis, or conjugation, effectively altering the drug's chemical properties and reducing its pharmacological activity. The specific pathways and enzymes involved depend on the drug in question.

Pharmacodynamics

The pharmacodynamics of drug inactivation involves the relationship between drug concentration and effect. As a drug undergoes inactivation, its concentration decreases, leading to reduced therapeutic effects. This is crucial in determining dosing regimens and understanding drug interactions, as co-administered drugs may affect the rate of inactivation, either enhancing or diminishing the therapeutic response.

Pharmacokinetics

Pharmacokinetics of drug inactivation encompasses the absorption, distribution, metabolism, and excretion of drugs. Inactivation typically occurs during the metabolism phase, where the liver plays a significant role through phase I and phase II reactions. The rate of inactivation can vary greatly between individuals due to genetic factors, age, liver function, and the presence of other medications that may induce or inhibit metabolic enzymes.

Pregnancy

Inactivation refers to the process of rendering a drug inactive, which may vary based on the specific drug and its mechanism of metabolism. The implications during pregnancy depend on the drug being inactivated.

Breast-feeding

The effects of inactivation during breastfeeding are contextual and depend on the specific drug involved. Generally, if a drug is inactivated, it may have reduced transfer into breast milk, but this must be evaluated on a case-by-case basis.

Storage

Storage conditions for inactivation depend on the specific drug and its formulation. Generally, medications should be stored in accordance with their labeling, considering factors like temperature, light, and humidity.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: rabies

Rabies is a viral disease caused by the rabies virus, which primarily affects mammals, including humans. It is transmitted through the saliva of infected animals, commonly via bites. The disease is characterized by encephalitis and can lead to severe neurological symptoms, and is often fatal if not treated promptly. Vaccination is a critical preventive measure, particularly for individuals at high risk of exposure, such as veterinary staff and travelers to endemic areas.

Indications

  • Rabies prevention in individuals at high risk of exposure
  • Post-exposure prophylaxis following potential rabies exposure
  • Vaccination for travelers to endemic regions

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations for pediatric patients.

Adults: Refer to the BNF for specific dosing guidelines, as it varies based on exposure risk and vaccination history.

Mechanism of action

The rabies vaccine works by stimulating the immune system to produce antibodies against the rabies virus. This is achieved through the introduction of inactivated or attenuated virus particles, which mimic the infection without causing the disease. The immune response generated helps to prevent the virus from causing illness upon subsequent exposure.

Pharmacodynamics

The rabies vaccine induces an adaptive immune response, leading to the production of neutralizing antibodies specific to the rabies virus. This immune memory protects against future infections. The vaccine is typically administered in a series of doses to ensure adequate immune response and long-term protection.

Pharmacokinetics

The pharmacokinetics of the rabies vaccine involve absorption at the injection site, followed by systemic distribution of the antigens. The onset of immunity generally occurs within two weeks after the initial vaccination, with peak antibody levels typically reached within one to two months. The duration of immunity can vary, necessitating booster doses in certain populations.

Interactions

  • chloroquine+rabiesvaccine: Severe (decreases efficacy)

Pregnancy

Rabies vaccination is generally considered safe during pregnancy. However, the risks and benefits should be carefully evaluated.

Breast-feeding

Rabies vaccine is not known to cause any adverse effects in breastfeeding. However, consult with a healthcare provider for individual assessments.

Storage

Store the rabies vaccine in a refrigerator at 2-8 degrees Celsius. Do not freeze.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: virus

Viruses are submicroscopic infectious agents that replicate only inside the living cells of an organism. They are composed of genetic material (either DNA or RNA) surrounded by a protein coat and, in some cases, an outer lipid envelope. Viruses can infect all types of life forms, from animals and plants to microorganisms, including bacteria (bacteriophages). They are responsible for a wide range of diseases, from the common cold to serious conditions such as HIV/AIDS, influenza, and COVID-19.

Indications

  • Influenza
  • HIV/AIDS
  • Hepatitis B and C
  • Herpes simplex virus infections
  • Cytomegalovirus infections
  • COVID-19
  • Respiratory syncytial virus infections

Dosage

Children: Refer to specific antiviral agents for dosing guidance.

Adults: Refer to specific antiviral agents for dosing guidance.

Mechanism of action

Viruses infect host cells by attaching to specific receptors on the cell surface. Once inside, they hijack the host cell's machinery to replicate their genetic material and produce viral proteins. New viral particles are assembled and released from the host cell, often destroying the cell in the process. The specific mechanism can vary depending on the virus type, including integration into the host genome in retroviruses or utilizing specific pathways for replication.

Pharmacodynamics

The pharmacodynamics of antiviral agents depend on the specific virus and the mechanism of action. Antiviral drugs may inhibit viral entry into host cells, block viral replication, or prevent the assembly of new virions. The effectiveness of antiviral therapy often relates to the stage of viral replication and the immune response of the host.

Pharmacokinetics

Pharmacokinetics of antiviral drugs varies widely based on the specific medication used. Generally, antiviral agents are absorbed through the gastrointestinal tract and distributed throughout the body. They may undergo hepatic metabolism and are often excreted through the kidneys. The half-life of these drugs can range from a few hours to several days, influencing dosing schedules.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.